Breaking News

QLT Considers Selloff

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

QLT Inc. has formed a Special Committee to “review all strategic alternatives available,” according to a company statement. The committee, comprised of three independent directors from the board, has appointed Morrison & Foerster, LLP as legal counsel. The committee has been charged, among other things with the responsibility for “exploring alternative ways to maximize shareholder value,” including a selloff of all or part of the company. QLT’s board is revie...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters